Projects funded by the NCN
Chimeric Rhodopsin as a novel optogenetic tool
2023/48/C/NZ5/00081
Keywords:
retina rhodopsin GPCRs AAV gene therapy
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_8: Animal disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Chemii Fizycznej Polskiej Akademii Nauk, Międzynarodowe Centrum Badań Oka
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: SONATINA 7 - announced on 2022-11-29
Amount awarded: 1 229 001 PLN
Project start date (Y-m-d): 2023-10-02
Project end date (Y-m-d): 2026-10-01
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.